These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 14566008

  • 1. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA, Watts VJ.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [Abstract] [Full Text] [Related]

  • 2. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG, Watts VJ.
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [Abstract] [Full Text] [Related]

  • 3. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
    Vortherms TA, Nguyen CH, Bastepe M, Jüppner H, Watts VJ.
    Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
    [Abstract] [Full Text] [Related]

  • 4. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD, Senogles SE, Bunzow JR, Liggett SB, Civelli O, Caron MG.
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [Abstract] [Full Text] [Related]

  • 5. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
    Boundy VA, Pacheco MA, Guan W, Molinoff PB.
    Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
    [Abstract] [Full Text] [Related]

  • 6. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ, Neve KA.
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [Abstract] [Full Text] [Related]

  • 7. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
    Zhang LJ, Lachowicz JE, Sibley DR.
    Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
    [Abstract] [Full Text] [Related]

  • 8. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
    Jarrahian A, Watts VJ, Barker EL.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
    [Abstract] [Full Text] [Related]

  • 9. Using molecular tools to dissect the role of Galphas in sensitization of AC1.
    Vortherms TA, Nguyen CH, Berlot CH, Watts VJ.
    Mol Pharmacol; 2004 Dec; 66(6):1617-24. PubMed ID: 15361543
    [Abstract] [Full Text] [Related]

  • 10. Novel regulatory properties of human type 9 adenylate cyclase.
    Cumbay MG, Watts VJ.
    J Pharmacol Exp Ther; 2004 Jul; 310(1):108-15. PubMed ID: 14996950
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
    Yamaguchi I, Walk SF, Jose PA, Felder RA.
    Mol Pharmacol; 1996 Feb; 49(2):373-8. PubMed ID: 8632772
    [Abstract] [Full Text] [Related]

  • 12. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
    Tozzi A, Tscherter A, Belcastro V, Tantucci M, Costa C, Picconi B, Centonze D, Calabresi P, Borsini F.
    Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance).
    Yao L, Asai K, Jiang Z, Ishii A, Fan P, Gordon AS, Diamond I.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):833-9. PubMed ID: 11454949
    [Abstract] [Full Text] [Related]

  • 14. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
    Beazely MA, Watts VJ.
    Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
    [Abstract] [Full Text] [Related]

  • 15. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA, Beazely MA, Vancura AF, Wang JK, Watts VJ.
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [Abstract] [Full Text] [Related]

  • 16. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM, Artymyshyn RP, Guan W, Molinoff PB.
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [Abstract] [Full Text] [Related]

  • 17. Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
    Watts VJ, Wiens BL, Cumbay MG, Vu MN, Neve RL, Neve KA.
    J Neurosci; 1998 Nov 01; 18(21):8692-9. PubMed ID: 9786976
    [Abstract] [Full Text] [Related]

  • 18. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF.
    Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):91-100. PubMed ID: 17913243
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
    Watts VJ, Neve KA.
    Pharmacol Ther; 2005 Jun 15; 106(3):405-21. PubMed ID: 15922020
    [Abstract] [Full Text] [Related]

  • 20. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
    Black LE, Smyk-Randall EM, Sibley DR.
    Mol Cell Neurosci; 1994 Dec 15; 5(6):567-75. PubMed ID: 7704430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.